Get started
Author

Uwe Klueppelberg

On the Unique Structural Organization of the Saccharomyces cerevisiae Pyruvate Dehydrogenase Complex
1997 · James K. Stoops, R.Holland Cheng, et al. · Journal of Biological Chemistry · 64
Clinical correlates of infection with human herpesvirus-6.
1994 · G R Krueger, U Klueppelberg, et al. · PubMed · 53
Alleles of the alpha-1-antitrypsin phenotype in patients with aortic aneurysms.
1998 · H M Schardey, T Hernandez-Richter, et al. · PubMed · 18
Demonstration of active and latent Epstein-Barr virus and human herpevirus-6 infections in bone marrow cells of patients with myelodysplasia and chronic myeloproliferative diseases.
1994 · G R Krueger, D Kudlimay, et al. · PubMed · 15
Semi-quantitative in situ hybridization and immunohistology for antigen expression of human herpesvirus-6 in various lymphoproliferative diseases.
1994 · J Rojo, V E Ferrer Argote, et al. · PubMed · 7
Non-specific interstitial pneumonia (NIP): immunohistologic screening of etiologic agents.
1994 · A Ostermann, U Klueppelberg, et al. · PubMed · 5
Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Low-Dose Thalidomide in Combination with Dexamethasone and Zoledronate: A Phase II Trial.
2005 · Uwe Klueppelberg, Iuliana Shapira, et al. · Blood · 1
Long-term treatment of newly-diagnosed multiple myeloma with low-dose thalidomide, dexamethasone and zoledronate (TDZ)
2005 · U. Klueppelberg, I. Shapira, et al. · Journal of Clinical Oncology · 1
A Single Center Experience with Using Dose-Adjusted Repoch in Elderly Patients with Large B-Cell Lymphoma
2023 · Trevor Hodson, Alexis Altmaier, et al. · Blood
PDF
Endothelial Progenitor Cells within the Bone Marrow Microenvironment of Multiple Myeloma Patients Display Stem Cell Traits.
2009 · Sadeaqua S. Scott, Marc J. Braunstein, et al. · Blood
Treatment of multiple myeloma with thalidomide, dexamethasone, and zoledronate in an inner-city population with high prevalence of HIV/AIDS
2007 · Uwe Klueppelberg, Eric L. Smith, et al. · Cancer Epidemiology and Prevention Biomarkers
Differential Effects of Hsp70 Inhibition within the Tumor and Microenvironment in Multiple Myeloma.
2006 · Marc J. Braunstein, Na Liu, et al. · Blood
Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Zoledronate, Dexamethasone, and Low-Dose Thalidomide: A Phase II Trial.
2006 · Uwe Klueppelberg, Eric L.P. Smith, et al. · Blood
Endothelial progenitor cell clonality and response to treatment in multiple myeloma
2006 · D. M. Kahn, M. Braunstein, et al. · Journal of Clinical Oncology
Treatment of newly diagnosed, inner-city multiple myeloma patients with low-dose thalidomide and dexamethasone and zoledronate
2006 · U. H. Klueppelberg, D. M. Kahn, et al. · Journal of Clinical Oncology
Evidence for Clonality in Circulating Endothelial Progenitor Cells in Multiple Myeloma.
2004 · Tayfun Ozcelik, Varsha Vakil, et al. · Blood
First-Line Treatment of Multiple Myeloma with a Combination of Thalidomide, Dexamethasone, and Zoledronate (TDZ) in an Inner-City Population with High HIV Prevalence.
2004 · Uwe Klueppelberg, Eric Smith, et al. · Blood
First-line, long-term treatment of multiple myeloma with thalidomide, dexamethasone, and zoledronate in combination (TDZ)
2004 · U. Klueppelberg, L. Chen, et al. · Journal of Clinical Oncology
Works count: 18
Citation count: 164
H-index: 5
I10-index: 4
Year
Topic
Type